Intuitive Surgical, Inc. $ISRG Shares Sold by Hillsdale Investment Management Inc.

Hillsdale Investment Management Inc. trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 60.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,460 shares of the medical equipment provider’s stock after selling 2,269 shares during the quarter. Hillsdale Investment Management Inc.’s holdings in Intuitive Surgical were worth $827,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in ISRG. JTC Employer Solutions Trustee Ltd acquired a new stake in Intuitive Surgical in the 4th quarter valued at approximately $227,000. Fideuram Asset Management Ireland dac acquired a new stake in Intuitive Surgical in the 4th quarter valued at approximately $5,035,000. FUKOKU MUTUAL LIFE INSURANCE Co increased its position in Intuitive Surgical by 68.9% in the 4th quarter. FUKOKU MUTUAL LIFE INSURANCE Co now owns 2,894 shares of the medical equipment provider’s stock valued at $1,639,000 after acquiring an additional 1,181 shares during the period. National Pension Service increased its position in Intuitive Surgical by 3.4% in the 4th quarter. National Pension Service now owns 728,944 shares of the medical equipment provider’s stock valued at $412,845,000 after acquiring an additional 23,899 shares during the period. Finally, Operose Advisors LLC increased its position in Intuitive Surgical by 21.3% in the 4th quarter. Operose Advisors LLC now owns 672 shares of the medical equipment provider’s stock valued at $380,000 after acquiring an additional 118 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts recently commented on ISRG shares. BTIG Research restated a “buy” rating and issued a $574.00 target price on shares of Intuitive Surgical in a research report on Wednesday, April 22nd. Evercore lowered their target price on Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating on the stock in a research report on Monday, April 6th. Piper Sandler lowered their target price on Intuitive Surgical from $620.00 to $580.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. HSBC lowered their target price on Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Finally, Bank of America lowered their target price on Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating on the stock in a research report on Monday, May 18th. Nineteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $576.71.

Insiders Place Their Bets

In other news, SVP Mark Brosius sold 645 shares of the firm’s stock in a transaction on Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the completion of the sale, the senior vice president owned 1,613 shares of the company’s stock, valued at $782,321.13. This trade represents a 28.57% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP Myriam Curet sold 105 shares of the firm’s stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total value of $51,864.75. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 4,833 shares of company stock worth $2,357,582. 0.60% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Down 2.9%

ISRG opened at $412.26 on Tuesday. The firm has a market cap of $146.01 billion, a PE ratio of 49.97, a P/E/G ratio of 3.39 and a beta of 1.46. The business has a fifty day simple moving average of $452.19 and a 200-day simple moving average of $504.81. Intuitive Surgical, Inc. has a fifty-two week low of $411.83 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, topping the consensus estimate of $2.08 by $0.42. The business had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.Intuitive Surgical’s revenue was up 23.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.81 earnings per share. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 8.57 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.